T
LKFT

Tidemark’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Tidemark’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300 Hold
10
– – ﹤0.01% 872
2026
Q1 		$300 Buy
+10
New +$331 ﹤0.01% 823

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Tidemark's LKFT Position: Q2 2026 in Review

Tidemark held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q2 2026 at 10 shares worth $300. The position accounts for ﹤0.01% of the portfolio, ranked #872.

Tidemark first reported a position in LKFT in Q1 2026 and has held it in 2 quarters since. 77 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Tidemark held 10 shares of Lakefront Biotherapeutics American Depositary Shares worth $300 as of Q2 2026.
  • Tidemark left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q2 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #872 holding.
  • Tidemark first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2026 and has held it in 2 quarters since.
  • 77 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.